SEPCIDIN
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Sept 2013)
What this means for you
This application is over — abandoned 09 Sept 2013. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77922972
- Mark type
- Stylized text
- Filed
- 28 Jan 2010
- Published for opposition
- 15 Jun 2010
- Abandoned
- 09 Sept 2013
- Attorney of record
- Lisa M. Martens
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention, prophylaxis, containment, and treatment of infectious disease and viral illness, namely, Influenza, Parainfluenza, Respiratory Syncitial Virus, Filovirus, Ebola Virus, Marburg Virus, and Viral Hemorrhagic Fever, immunological disorders, inflammation, inflammatory diseases, Respiratory diseases, Black Lung, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Cystic Fibrosis, Hepatitis, High Blood Pressure, Systemic Inflammatory Response Syndrome (SIRS), Severe Acute Respiratory Syndrome (SARS), Sepsis, Septic Shock, Toxic Shock Syndrome
Owner
- ANSUN BIOPHARMA, INC., SAN DIEGO, CA, US
- NexBio, Inc., San Diego, CA, US
- NexBio, Inc., San Diego, CA, US
Prosecution history
- 11 Dec 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Sept 2013 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 09 Sept 2013 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Mar 2013 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 05 Feb 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2013 — SOU EXTENSION 5 GRANTED
- 28 Jan 2013 — SOU EXTENSION 5 FILED
- 28 Jan 2013 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2013 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Jan 2013 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Jul 2012 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jul 2012 — SOU EXTENSION 4 GRANTED
- 09 Jul 2012 — SOU EXTENSION 4 FILED
- 09 Jul 2012 — SOU TEAS EXTENSION RECEIVED
- 31 Jan 2012 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED